PIMCO Dynamic Income Str... (NYSE:PDX)
Historical Stock Chart
From Jan 2020 to Jan 2025
Pediatrix Medical Group, Inc., (NYSE:PDX) today announced that it has
completed the acquisition of a pediatric cardiology practice based in
Pembroke Pines, Florida, that serves patients in communities in
northwest Miami-Dade and western Broward counties.
The practice was founded in 2002 by Raul Aguirre, M.D., who has more
than 12 years’ experience practicing pediatric
cardiology in South Florida. Dr. Aguirre’s
practice provides a range of cardiology services to pediatric patients.
The practice also has a thriving referral base from obstetricians and
maternal-fetal medicine specialists for fetal echocardiography services.
“The more we know about congenital heart
defects, the greater the need for fetal echocardiography services,”
said Raul Aguirre, M.D. “As part of Pediatrix,
I believe we have an excellent opportunity to build a recognized program
for patients in our communities.”
Pediatrix paid cash for the practice, which is expected to contribute
immediately to earnings per share.
About Pediatrix
Pediatrix Medical Group, Inc. is the nation’s
leading provider of neonatal, maternal-fetal and pediatric physician
subspecialty services and recently expanded to include anesthesiology
services. Pediatrix physicians and advanced practitioners are reshaping
the delivery of care within the maternal-fetal, neonatal intensive care
and pediatric cardiology subspecialties, using evidence-based tools,
continuous quality initiatives and clinical research to enhance patient
outcomes and provide high-quality, cost-effective care. Founded in 1979,
its neonatal physicians provide services at more than 240 neonatal
intensive care units, and in many markets they collaborate with
affiliated maternal-fetal medicine, pediatric cardiology physician
subspecialists and pediatric intensivists to provide a clinical care
continuum. Combined, Pediatrix and its affiliated professional
corporations employ more than 1,050 physicians in 32 states and Puerto
Rico. Pediatrix is also the nation’s largest
provider of newborn hearing screens. Additional information is available
at www.pediatrix.com.
Certain statements and information in this press release may be
deemed to be “forward-looking statements”
within the meaning of the Federal Private Securities Litigation Reform
Act of 1995. Forward-looking statements may include, but are not
limited to, statements relating to our objectives, plans and strategies,
and all statements (other than statements of historical facts) that
address activities, events or developments that we intend, expect,
project, believe or anticipate will or may occur in the future are
forward-looking statements. These statements are often characterized by
terminology such as “believe”,
“hope”, “may”,
“anticipate”, “should”,
“intend”, “plan”,
“will”, “expect”,
“estimate”, “project”,
“positioned”, “strategy”
and similar expressions, and are based on assumptions and assessments
made by Pediatrix’s management in light of
their experience and their perception of historical trends, current
conditions, expected future developments and other factors they believe
to be appropriate. Any forward-looking statements in this press release
are made as of the date hereof, and Pediatrix undertakes no duty to
update or revise any such statements, whether as a result of new
information, future events or otherwise. Forward-looking statements are
not guarantees of future performance and are subject to risks and
uncertainties. Important factors that could cause actual results,
developments, and business decisions to differ materially from
forward-looking statements are described in Pediatrix’s
most recent Annual Report on Form 10-K, including the section entitled “Risk
Factors”.